Decision letter for "Predictors of treatment response in type‐2 diabetes patients initiating basal‐supported oral therapy with insulin glargine 100 U/mL – a sub‐analysis of the Titration and OPtimisation (TOP) registry"
Keyword(s):
2019 ◽
Keyword(s):
2019 ◽
Keyword(s):
2019 ◽
Keyword(s):
2019 ◽
Vol 21
(9)
◽
pp. 2169-2173
◽
Keyword(s):
2019 ◽
Keyword(s):
2019 ◽
Effectiveness and safety of basal supported oral therapy with insulin glargine, in Japanese insulin-naive, type 2 diabetes patients, with or without microvascular complications: subanalysis of the observational, non-interventional, 24-week follow-up Add-on Lantus® to Oral Hypoglycemic Agents (ALOHA) study
2015 ◽
Vol 29
(1)
◽
pp. 127-133
◽